Delivery Order SPE2DB22D1017-SPE2DB24FF7TV

Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a potential value of $3,490.81 and a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,596.30, is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract was awarded on November 14, 2024, with a completion date of November 15, 2024, and has a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,472.66 award is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025 as the prime contractor to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,677.48, is for the supply of Mesalamine ER 0.375 gram capsules. The contract is a Firm Fixed Price (FFP) type and has an ultimate completion date of July 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,300.50 and is a firm fixed-price contract for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a medical product. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of MESALAMINE ER 0.375 GRAM CAP 120S, a prescription medication. The contract has a ceiling value of $3,585.22 and a completion date of July 2, 2024. This is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp. for the supply of Mesalamine ER 0.375 gram capsules. The contract has a ceiling value of $10,911.93 and an ultimate completion date of September 10, 2024. It is a firm-fixed-price contract type. The award is not associated with a set-aside program. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is a delivery order with a ceiling value of $4,266.70, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, with a completion date of September 19, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,896.72 firm fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF7TV
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the provision of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a firm fixed price of $2,195.35 and a completion date of May 17, 2024.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is providing this medication under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/15/24, 9:36 AM